Corresponding author

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Pharmaceutical Manufacturing Assessment, Division of Biotechnology Manufacturing, Branch 2

Reyes Candau-Chacon, Ph.D.

Impact of Container Closure on Drug Safety
Thursday, February 27, 2020
Pharmaceutical product container closure systems (CCS) should be designed to ensure that a drug product (1) is protected from factors that may impact product quality over its shelf life, including light, evaporation, exposure... read more